DOCSLIB.ORG

(12) United States Patent (10) Patent No.: US 7927,859 B2 San Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(12) United States Patent (10) Patent No.: US 7927,859 B2 San Et Al USOO7927859B2 (12) United States Patent (10) Patent No.: US 7927,859 B2 San et al. (45) Date of Patent: Apr. 19, 2011 (54) HIGH MOLARSUCCINATEYIELD FOREIGN PATENT DOCUMENTS BACTERIA BY INCREASING THE WO WO99.06532 * 2/1999 INTRACELLULAR NADHAVAILABILITY WO WO 2007 OO1982 1, 2007 OTHER PUBLICATIONS (75) Inventors: Ka-Yiu San, Houston, TX (US); George N. Bennett, Houston, TX (US); Ailen Branden et al. Introduction to Protein Structure, Garland Publishing Inc., New York, p. 247, 1991.* Sánchez, Houston, TX (US) ExPASy. Formate Dehydrogenase.* Vemuri et al. Effects of growth mode and pyruvate carboxylase on (73) Assignee: Rice University, Houston, TX (US) Succinic acid production by metabolically engineered strains of Escherichia coli. Appl Environ Microbiol. Apr. 2002:68(4): 1715 (*) Notice: Subject to any disclaimer, the term of this 27.3 patent is extended or adjusted under 35 Goodbye et al. Cloning and sequence analysis of the fermentative alcohol-dehydrogenase-encoding gene of Escherichia coli. Gene. U.S.C. 154(b) by 791 days. Dec. 21, 1989;85(1):209-14.* Datsenko et al. One-step inactivation of chromosomal genes in (21) Appl. No.: 10/923,635 Escherichia coli K-12 using PCR products. Proc Natl AcadSci USA. Jun. 6, 2000:97(12):6640-5.* (22) Filed: Aug. 20, 2004 Berrios-Rivera et al. Metabolic engineering of Escherichia coli: increase of NADHavailability by overexpressing an NAD(+)-depen (65) Prior Publication Data dent formate dehydrogenase. Metab Eng. Jul. 2002;4(3):217-29.* Gupta et al. Escherichia coli derivatives lacking both alcohol US 2005/OO42736A1 Feb. 24, 2005 dehydrogenase and phosphotransacetylase grow anaerobically by lactate fermentation. J Bacteriol. Jul. 1989; 171(7):3650-5.* Related U.S. Application Data Alam, Ketal. Anaerobic fermentation balance of E. coli as observed by in vivo nuclear magnetic resonance spectroscopy; J. of Bacteriol (60) Provisional application No. 60/497, 195, filed on Aug. ogy, vol. 171 (11), pp. 6213-7, Nov. 1989. 22, 2003. Aristidou AA, San Ky, Bennett GN. Metabolic engineering of Escherichia coli to enhance recombinant protein production through (51) Int. Cl. acetate reduction. Biotechnol Prog. Jul.-Aug. 1995; 11(4):475-8. CI2N I/20 (2006.01) Aristidou AA, San Ky, Bennett GN. Metabolic flux analysis of CI2N 9/02 (2006.01) Escherichia coli expressing the Bacillus subtilis acetolactate CI2N 9/04 (2006.01) Synthase in batch and continuous cultures. Biotechnol Bioeng. Jun. 20, 1999:63(6): 737-49. CI2N 9/10 (2006.01) Gokarn, R. R.; Eiteman, M. A.; Altman, E. Expression of pyruvate CI2N IS/00 (2006.01) carboxylase enhances Succinate production in Escherichia coli with CI2P 7/64 (2006.01) out affecting glucose uptake rate. Biotech. Let. 1998, 20, 795-798. CI2P 2L/04 (2006.01) U.S. Appl. No. 10/923,635, filed Aug. 20, 2004, San et al. CI2O I/68 (2006.01) U.S. Appl. No. 10/987,511, filed Nov. 12, 2004, San et al. CI2O I/00 (2006.01) U.S. Appl. No. 10/286,326, filed Nov. 2, 2002, San et al. C7H 2L/04 (2006.01) U.S. Appl. No. 60/604,922, filed Aug. 27, 2004, San et al. C7H 2L/02 (2006.01) U.S. Appl. No. 60/599.956, filed Aug. 9, 2004, San et al. U.S. Appl. No. 60/610,750, filed Sep. 17, 2004, San et al. (52) U.S. Cl. ................... 435/252.33; 435/189: 435/190; U.S. Appl. No. 60/638,765, filed Dec. 22, 2004, San et al. 435/.440; 435/252.3:435/320.1; 435/4; 435/6; Gokarn, R. R.; Eiteman, M. A.; Altman, E. Metabolic analysis of 435/193:435/135; 435/69.1:536/23.2:536/23.1 Escherichia coli in the presence and absense of the carboxylating (58) Field of Classification Search ........................ None enzymes phosphoenolpyruvate carboxylase and pyruvate See application file for complete search history. carboxylase. Appl Environ Microbiol. 2000, 666, 1844-1850. (56) References Cited (Continued) U.S. PATENT DOCUMENTS Primary Examiner —Yong D Pak 6,159,738 A 12/2000 Donnelly et al. (74) Attorney, Agent, or Firm — Boulware & Valoir 6,448,061 Bl 9, 2002 Panet al. 6,455.284 B1 9, 2002 Gokarn et al. (57) ABSTRACT 2003, OO87381 A1 5, 2003 Gokarn et al. 2006,0040368 A1 2/2006 San et al. The invention relates to increasing the yield of Succinate in 2006,004.6288 A1 3, 2006 Ka-Yiu et al. bacteria by increasing the intracellular availability of cofac 2006, OO73577 A1 4/2006 Ka-Yiu et al. tors such as NADH. 2006.0128001 A1 6, 2006 Yukawa et al. 2006, O141594 A1 6, 2006 San et al. 18 Claims, 4 Drawing Sheets US 7,927,859 B2 Page 2 OTHER PUBLICATIONS membrane-driven fumarate reduction and energy conservation; J. of Bacteriology, vol. 181 (8), pp. 2403-2410, Apr. 1999. Hahm, D. H.; Pan, J. G.; Rhee, J. S. Characterization and evaluation Phillips, G. J.; Park, S. K.; Huber, D. High copy number plasmids of a pta (phosphotransacetylase) negative mutant of Escherichia coli compatible with commonly used cloning vectors. Biotechniques. HZB101 as a production host of foreign lipase. Appl Microbiol 2000, 28, 400-408. San KY, Bennett GN. Berrios-Rivera SJ, Vadali RV.YangYT, Horton Biotechnol. 1994, 42, 100-107. E. Rudolph FB, Sariyar B, Blackwood K. Metabolic engineering Holms, W. H. The central metabolic pathways in Escherichia coli: through cofactor manipulation and its effects on metabolic flux redis relationship between flux and control at a branchpoint, efficiency of tribution in Escherichia coli. Metab Eng. Apr. 2002:4(2): 182-92. conversion to biomass, and excretion of acetate. Curr Top Cell Regul. Sanchez, A. M.; Bennett, G. N.; San, K.-Y. Efficient Succinate pro 1986, 28, 69-105. duction from glucose through overexpression of pyruvate Hong, S. H.; Lee, S.-Y. Importance of redox balance on the produc carboxylase in an Escherichia coli alcohol dehydrogense and lactate tion of Succinic acid by metabolically engineered Escherichia coli. dehydrogenase mutant. Submitted. 2004a. Appl Microbiol Biotechnol. 2002, 58,286-290. Vemuri, G.N.: Eiteman, M. A.; Altman, E. Effect of growth mode and Leonardo, M. et al., Anaerobic regulation of the adhE gene, encoding pyruvate carboxylase on Succinic acid production by metabolically the fermentative alcoholdehydrogenase of E. coli: J. of Bacteriology, engineered strains of Escherichia coli. Appl Environ Microbiol. vol. 175(3), pp. 870-8, Feb. 1993. 2002, 68, 1715-1727. Levanon SS, San KY, Bennett GN. Effect of oxygen on the Yang YT, Aristidou AA, San KY, Bennett GN. Metabolic flux analy Escherichia coli ArcA and FNR regulation systems and metabolic sis of Escherichia coli deficient in the acetate production pathway responses. Biotechnol Bioeng. Mar. 5, 2005;89(5):556-64. and expressing the Bacillus subtilis acetolactate synthase. Metab Lin H. San KY, Bennett GN. Effect of Sorghum vulgare Eng. Jan. 1999; 1(1):26-34. phosphoenolpyruvate carboxylase and Lactococcus lactis pyruvate Yang YT, Bennett GN. San KY. Effect of inactivation of nuo and carboxylase coexpression on Succinate production in mutant strains ackA-pta on redistribution of metabolic fluxes in Escherichia coli. of Escherichia coli. Appl Microbiol Biotechnol. Nov. 24, 2004; Biotechnol Bioeng. Nov. 5, 1999:65(3):291-7. Epub ahead of print. Yang YT. Bennett GN. San KY. The effects offeed and intracellular Lin H. Vadali RV. Bennett GN. San KY. Increasing the acetyl-CoA pyruvate levels on the redistribution of metabolic fluxes in pool in the presence of overexpressed phosphoenolpyruvate Escherichia coli. Metab Eng. Apr. 2001:3(2): 115-23. carboxylase or pyruvate carboxylase enhances succinate production Yang YT, Peredelchuk M. Bennett GN, San KY. Effect of variation of in Escherichia coli. Biotechnol Prog. Sep.-Oct. 2004:20(5): 1599 Klebsiella pneumoniae acetolactate synthase expression on meta 604. bolic flux redistribution in Escherichia coli. Biotechnol Bioeng. Jul. Luli. G. W.; Strohl, W. R. Comparison of growth, acetate production, 20, 2000:69(2): 150-9. and acetate inhibition of Escherichia coli strains in batch and fed San, Ka-Yiu et al. Metabolic Engineering through Cofactor Manipu batch fermentations. Applied and Environmental Microbiology. lation and its Effects on Metabolic Flux Redistribution in Escherichia 1990, 56, 1004-1011. coli, Metabolic Engineering 4, pp. 182-192,(2002). Park. D. et al., Utilization of electrically reduced neutral red by Actinobacillus succinogenes: physiological functio of neutral red in * cited by examiner U.S. Patent Apr. 19, 2011 Sheet 1 of 4 US 7927,859 B2 Glucose PEP PTSG Pyruvate Glucose-6-P - ATP ADP Fructose 1,6-diF w Glyceraldehyde-3-P --- Dihydroxyacetone-P Succinate P+NAD+ NADH Glycerate-1,3-diP 2NAD- v ADP NADH Co, - ATP ls1. y:-ADP OAA NN -r LDH Lactate PYC Pyruvate NADH NAD PFL Formate Acetyl-CoA - -- Acetyl-P PTA CO 2 --" ALDH ACK ADP ADH 2NADH ATP H2 2NAD Acetate Ethanol FIG. I. U.S. Patent Apr. 19, 2011 Sheet 2 of 4 US 7927,859 B2 Succinate Yield O 100 Fomate Conc. (mM) SBS110 (pDHC30+pHL413) is SBS110 (pASF2+pHL413) B C D Lactate Yield Acetate Yield as2 1.0 m -os----------------...s.n.m.- : 10 a.m...a...a.................... a2 0.25 0.8 is 0.20 -- S 0.6 a 0.15 3 3 g 0.4 3 0.10 02 0.05 g D 0.0 000 O 10 Fomate Conc. (mM) Formate Conc (mM) Formate Conc. (mM) SBS11 O(pDHC30-pHL413) SBS11 OcpASF2-phLA13) FIG 2 U.S. Patent Apr. 19, 2011 Sheet 3 of 4 US 7927,859 B2 Ghucose Consumed 40 120 100 Formate Acetate 11 ESBS110MG(pTRC99A) SBS110MG(pHLA 13) OSBS220MG(pHLA 13) Succinate Formate Acetate FIG. 3 U.S. Patent Apr. 19, 2011 Sheet 4 of 4 US 7927,859 B2 A B Ghucose Consumed 140 140 a loo120 S.gol 120 E 80 2 80 - - 60 9 60 2 40 5 40 Od 20 O 20 0 O 48 96 168 48 96 168 C 100 to 80 e a 60 5 40 2 3 20 O O 48 96 168 Time (hrs) Time (hrs) E OSBS110MG(pHLA 13) an SBS880MGK(pHLA 13) s .32 > Time (hrs) FIG.
Load more

Recommended publications
  • Construction and Enzymatic Characterization of E
    1 Minimizing acetate formation in E. coli fermentations 2 Marjan De Mey*, Sofie De Maeseneire, Wim Soetaert and Erick Vandamme 3 Ghent University, Laboratory of Industrial Microbiology and Biocatalysis, Department of 4 Biochemical and Microbial Technology, Faculty of Bioscience Engineering, Coupure links 5 653, B-9000 Ghent, Belgium 6 7 * Correspondence address: Marjan De Mey 8 Laboratory of Industrial Microbiology and Biocatalysis 9 Department of Biochemical and Microbial Technology 10 Faculty of Bioscience Engineering 11 Ghent University 12 Coupure links 653 13 B-9000 Gent 14 Tel: +32-9-264-60-28 15 Fax: +32-9-264-62-31 16 [email protected] 17 Keywords: acetate reduction, Escherichia coli, metabolic engineering 1 18 Abstract 19 Escherichia coli remains the best established production organisms in industrial 20 biotechnology. However, during aerobic fermentation runs at high growth rates, considerable 21 amounts of acetate are accumulated as by-product. This by-product has negative effects on 22 growth and protein production. Over the last 20 years, substantial research efforts have been 23 spent to reduce acetate accumulation during aerobic growth of E. coli on glucose. From the 24 onset it was clear that this quest should not be a simple nor uncomplicated one. Simple 25 deletion of the acetate pathway, reduced the acetate accumulation, but instead other by- 26 products were formed. This minireview gives a clear outline of these research efforts and the 27 outcome of them, including bioprocess level approaches and genetic approaches. Recently, 28 the latter seems to have some promising results. 29 30 1 Introduction 31 Escherichia coli was the first and is still one of the most commonly used production 32 organisms in industrial biotechnology.
    [Show full text]
  • Harnessing Escherichia Coli for Bio-Based Production of Formate
    bioRxiv preprint doi: https://doi.org/10.1101/2021.01.06.425572; this version posted January 6, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Harnessing Escherichia coli for bio‐based production of formate under pressurized H2 and CO2 gases. Magali Roger1,2, Tom C. Reed2 and Frank Sargent2* 1 Aix Marseille University, CNRS, Bioenergetics and Protein Engineering (BIP UMR7281), 31 Chemin Joseph Aiguier, CS70071, 13042 Marseille Cedex 09, France. 2 School of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne, NE1 7RU, England, UK *For Correspondence: Prof Frank Sargent FRSE, Division of Plant & Microbial Biology, School of Natural & Environmental Sciences, Newcastle University, Devonshire Building, Kensington Terrace, Newcastle upon Tyne NE2 4BF, England, United Kingdom. T: +44 191 20 85138. E: [email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.01.06.425572; this version posted January 6, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. ABSRACT Escherichia coli is gram‐negative bacterium that is a workhorse of the biotechnology industry. The organism has a flexible metabolism and can perform a mixed‐acid fermentation under anaerobic conditions. Under these conditions E. coli synthesises a formate hydrogenlyase isoenzyme (FHL‐1) that can generate molecular hydrogen and carbon dioxide from formic acid.
    [Show full text]
  • Targeting Pyruvate Carboxylase Reduces Gluconeogenesis and Adiposity and Improves Insulin Resistance Naoki Kumashiro,1,2 Sara A
    ORIGINAL ARTICLE Targeting Pyruvate Carboxylase Reduces Gluconeogenesis and Adiposity and Improves Insulin Resistance Naoki Kumashiro,1,2 Sara A. Beddow,3 Daniel F. Vatner,2 Sachin K. Majumdar,2 Jennifer L. Cantley,1,2 Fitsum Guebre-Egziabher,2 Ioana Fat,2 Blas Guigni,2 Michael J. Jurczak,2 Andreas L. Birkenfeld,2 Mario Kahn,2 Bryce K. Perler,2 Michelle A. Puchowicz,4 Vara Prasad Manchem,5 Sanjay Bhanot,5 Christopher D. Still,6 Glenn S. Gerhard,6 Kitt Falk Petersen,2 Gary W. Cline,2 Gerald I. Shulman,1,2,7 and Varman T. Samuel2,3 – We measured the mRNA and protein expression of the key transcriptional factors and cofactors (8 12). Yet, despite gluconeogenic enzymes in human liver biopsy specimens and the high degree of transcription regulation for these found that only hepatic pyruvate carboxylase protein levels enzymes, the control they exert over gluconeogenic flux is related strongly with glycemia. We assessed the role of pyruvate relatively weak (13–16). We recently reported that hepatic carboxylase in regulating glucose and lipid metabolism in rats expression of PEPCK and G6PC mRNA was not related to through a loss-of-function approach using a specific antisense fasting hyperglycemia in two rodent models of type 2 di- oligonucleotide (ASO) to decrease expression predominantly in abetes and in patients with type 2 diabetes (17). Thus, we liver and adipose tissue. Pyruvate carboxylase ASO reduced hypothesized that other mechanisms must account for in- plasma glucose concentrations and the rate of endogenous glucose production in vivo. Interestingly, pyruvate carboxylase ASO also creased hepatic gluconeogenesis and fasting hyperglycemia reduced adiposity, plasma lipid concentrations, and hepatic in type 2 diabetes.
    [Show full text]
  • Citric Acid Cycle
    CHEM464 / Medh, J.D. The Citric Acid Cycle Citric Acid Cycle: Central Role in Catabolism • Stage II of catabolism involves the conversion of carbohydrates, fats and aminoacids into acetylCoA • In aerobic organisms, citric acid cycle makes up the final stage of catabolism when acetyl CoA is completely oxidized to CO2. • Also called Krebs cycle or tricarboxylic acid (TCA) cycle. • It is a central integrative pathway that harvests chemical energy from biological fuel in the form of electrons in NADH and FADH2 (oxidation is loss of electrons). • NADH and FADH2 transfer electrons via the electron transport chain to final electron acceptor, O2, to form H2O. Entry of Pyruvate into the TCA cycle • Pyruvate is formed in the cytosol as a product of glycolysis • For entry into the TCA cycle, it has to be converted to Acetyl CoA. • Oxidation of pyruvate to acetyl CoA is catalyzed by the pyruvate dehydrogenase complex in the mitochondria • Mitochondria consist of inner and outer membranes and the matrix • Enzymes of the PDH complex and the TCA cycle (except succinate dehydrogenase) are in the matrix • Pyruvate translocase is an antiporter present in the inner mitochondrial membrane that allows entry of a molecule of pyruvate in exchange for a hydroxide ion. 1 CHEM464 / Medh, J.D. The Citric Acid Cycle The Pyruvate Dehydrogenase (PDH) complex • The PDH complex consists of 3 enzymes. They are: pyruvate dehydrogenase (E1), Dihydrolipoyl transacetylase (E2) and dihydrolipoyl dehydrogenase (E3). • It has 5 cofactors: CoASH, NAD+, lipoamide, TPP and FAD. CoASH and NAD+ participate stoichiometrically in the reaction, the other 3 cofactors have catalytic functions.
    [Show full text]
  • Mechanism F Formation of Oxaloacetate and Phosphoenol Pyruvate from Pyruvate1
    THE JOURNAL OF VITAMINOLOGY 14, 59-67 (1968) MECHANISM F FORMATION OF OXALOACETATE AND PHOSPHOENOL PYRUVATE FROM PYRUVATE1 HARLAND G. WOOD Department of Biochemistry, Case Western Reserve University Cleveland, Ohio 44, 106, U.S.A. Pyruvate, oxaloacetate and P-enolpyruvate have been known to be key compounds in metabolism for many years; pyruvate since 1911 when Neuberg found that yeast decarboxylates pyruvate to acetaldehyde, oxaloacetate since 1937 when Krebs pro posed the citric acid cycle, and P-enolpyruvate since 1934-1936 when Lohmann, Meyerhof and Kiessling discovered that 3-phosphoglycerate is converted to P enolpyruvate by dialyzed yeast or muscle extracts. These three compounds are the hub of numerous reactions leading to both synthesis and breakdown of carbo hydrates, fats and nitrogenous compounds (See the recent review by Utter (1) ). Furthermore, they are interlocked within themselves by a series of reactions re sulting in the synthesis of each fromn the other with accompanying breakdown of the companion compound. There has been a long debate concerning the mechanism of formation of P enolpyruvate from pyruvate. The conversion of P-enolpyruvate to pyruvate in glycolysis by pyruvate kinase was shown by Lardy and Ziegler (2) in 1945 to be reversible, but the equilibrium lies far to the right and the physiological signi ficance of the reversibility is questionable. The possibility that P-enolpyruvate might be formed by a pathway other than via pyruvate kinase was first raised by Kalckar (3) who found that kidney preparations could form P-enolpyruvate from malate and fumarate. At that time Wood and Werkman had discovered fixation of CO2 by heterotrophs and had postulated that the fixation occurs by combination of CO2 with pyruvate to give oxaloacetate.
    [Show full text]
  • Pyruvate Carboxylase Signalling Axis Couples Mitochondrial Metabolism to Glucose-Stimulated Insulin Secretion in Pancreatic B-Cells
    ARTICLE Received 23 Oct 2015 | Accepted 26 Apr 2016 | Published 6 Jun 2016 DOI: 10.1038/ncomms11740 OPEN The MDM2–p53–pyruvate carboxylase signalling axis couples mitochondrial metabolism to glucose-stimulated insulin secretion in pancreatic b-cells Xiaomu Li1,2,3,*, Kenneth K.Y. Cheng1,2,*, Zhuohao Liu1,2, Jin-Kui Yang4, Baile Wang1,2, Xue Jiang1,2, Yawen Zhou1,2, Philip Hallenborg5, Ruby L.C. Hoo1,2, Karen S.L. Lam1,2, Yasuhiro Ikeda6, Xin Gao3 & Aimin Xu1,2,7 Mitochondrial metabolism is pivotal for glucose-stimulated insulin secretion (GSIS) in pancreatic b-cells. However, little is known about the molecular machinery that controls the homeostasis of intermediary metabolites in mitochondria. Here we show that the activation of p53 in b-cells, by genetic deletion or pharmacological inhibition of its negative regulator MDM2, impairs GSIS, leading to glucose intolerance in mice. Mechanistically, p53 activation represses the expression of the mitochondrial enzyme pyruvate carboxylase (PC), resulting in diminished production of the TCA cycle intermediates oxaloacetate and NADPH, and impaired oxygen consumption. The defective GSIS and mitochondrial metabolism in MDM2-null islets can be rescued by restoring PC expression. Under diabetogenic conditions, MDM2 and p53 are upregulated, whereas PC is reduced in mouse b-cells. Pharmacological inhibition of p53 alleviates defective GSIS in diabetic islets by restoring PC expression. Thus, the MDM2–p53–PC signalling axis links mitochondrial metabolism to insulin secretion and glucose homeostasis, and could represent a therapeutic target in diabetes. 1 State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Pok Fu Lam, Hong Kong. 2 Department of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong.
    [Show full text]
  • Pyruvate Carboxylase and Phosphoenolpyruvate Carboxykinase Activity in Leukocytes and Fibroblasts from a Patient with Pyruvate Carboxylase Deficiency
    Pediat. Res. 13: 3843 (1979) Citrate synthase lymphocytes fibroblasts phosphoenol pyruvate carboxykinase lactic acidosis pyruvate carboxylase pyruvate carboxylase deficiency Pyruvate Carboxylase and Phosphoenolpyruvate Carboxykinase Activity in Leukocytes and Fibroblasts from a Patient with Pyruvate Carboxylase Deficiency Division of Genetics and Departmenr of Pediatrics, Universiy of Oregon Health Sciences Center, Porrland, Oregon; and Department of Biochemistry, School of Medicine, Case Western Reserve Universi!,., Cleveland, Ohio, USA Summary complex (PDC) (7, 13, 32, 35), and PEPCK (14, 17,40). With the exception of PDC which catalyzes the first step in the Krebs cycle, Normal values are given for the activities of pyruvate carbox- the enzymes are necessary for gluconeogenesis in mammalian ylase (E.C. 6.4.1.1), mitochondrial phosphoenolpyruvate carboxy- renal cortex and liver. In addition to its gluconeogenic role. base (E.C. 4.1.1.32, PEPCK), and citrate synthase (E.C. 4.1.3.7) pyruvate carboxylase is required for the adequate operation of the in fibroblasts, lymphocytes, and leukocytes. Also given are values Krebs cycle because of its role in the replenishment of four-carbon for these enzymes in the leukocytes and fibroblasts from a severely Krebs cycle intermediates. Both the kitochondrial and cytosolic mentally and developmentally retarded patient with proximal renal forms of PEPCK are present in human liver. tubular acidosis and hepatic, cerebral, and renal cortical pyruvate Fructose 1,6-bisphosphatase (28) and PDC deficiency (7) have carboxylase deficiency. In normals, virtually all of the mitochon- been diagnosed in leukocytes and, although there are references drial PEPCK and pyruvate carboxylase activity was present in the to the presence of pyruvate carboxylase in fibroblasts (3.
    [Show full text]
  • Recent Progress in the Microbial Production of Pyruvic Acid
    fermentation Review Recent Progress in the Microbial Production of Pyruvic Acid Neda Maleki 1 and Mark A. Eiteman 2,* 1 Department of Food Science, Engineering and Technology, University of Tehran, Karaj 31587-77871, Iran; [email protected] 2 School of Chemical, Materials and Biomedical Engineering, University of Georgia, Athens, GA 30602, USA * Correspondence: [email protected]; Tel.: +1-706-542-0833 Academic Editor: Gunnar Lidén Received: 10 January 2017; Accepted: 6 February 2017; Published: 13 February 2017 Abstract: Pyruvic acid (pyruvate) is a cellular metabolite found at the biochemical junction of glycolysis and the tricarboxylic acid cycle. Pyruvate is used in food, cosmetics, pharmaceutical and agricultural applications. Microbial production of pyruvate from either yeast or bacteria relies on restricting the natural catabolism of pyruvate, while also limiting the accumulation of the numerous potential by-products. In this review we describe research to improve pyruvate formation which has targeted both strain development and process development. Strain development requires an understanding of carbohydrate metabolism and the many competing enzymes which use pyruvate as a substrate, and it often combines classical mutation/isolation approaches with modern metabolic engineering strategies. Process development requires an understanding of operational modes and their differing effects on microbial growth and product formation. Keywords: auxotrophy; Candida glabrata; Escherichia coli; fed-batch; metabolic engineering; pyruvate; pyruvate dehydrogenase 1. Introduction Pyruvic acid (pyruvate at neutral pH) is a three carbon oxo-monocarboxylic acid, also known as 2-oxopropanoic acid, 2-ketopropionic acid or acetylformic acid. Pyruvate is biochemically located at the end of glycolysis and entry into the tricarboxylic acid (TCA) cycle (Figure1).
    [Show full text]
  • Fumarate Respiration of Wolinella Succinogenes: Enzymology, Energetics and Coupling Mechanism
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biochimica et Biophysica Acta 1553 (2002) 23^38 www.bba-direct.com Review Fumarate respiration of Wolinella succinogenes: enzymology, energetics and coupling mechanism Achim Kro«ger a;*, Simone Biel a,Jo«rg Simon a, Roland Gross a, Gottfried Unden b, C. Roy D. Lancaster c a Institut fu«r Mikrobiologie, Johann Wolfgang Goethe-Universita«t, Marie-Curie-Str. 9, D-60439 Frankfurt am Main, Germany b Institut fu«r Mikrobiologie und Weinforschung, Johannes Gutenberg-Universita«t, D-55099 Mainz, Germany c Max-Planck-Institut fu«r Biophysik, Heinrich-Ho¡mann-Str. 7, D-60528 Frankfurt am Main, Germany Received 10 May 2001; received in revised form 27 August 2001; accepted 12 October 2001 Abstract Wolinella succinogenes performs oxidative phosphorylation with fumarate instead of O2 as terminal electron acceptor and H2 or formate as electron donors. Fumarate reduction by these donors (`fumarate respiration') is catalyzed by an electron transport chain in the bacterial membrane, and is coupled to the generation of an electrochemical proton potential (vp) across the bacterial membrane. The experimental evidence concerning the electron transport and its coupling to vp generation is reviewed in this article. The electron transport chain consists of fumarate reductase, menaquinone (MK) and either hydrogenase or formate dehydrogenase. Measurements indicate that the vp is generated exclusively by MK reduction with H2 or formate; MKH2 oxidation by fumarate appears to be an electroneutral process. However, evidence derived from the crystal structure of fumarate reductase suggests an electrogenic mechanism for the latter process.
    [Show full text]
  • NAD+-Dependent Formate Dehydrogenase from Plants
    reVIeWS NAD+-dependent Formate Dehydrogenase from Plants A.A. Alekseeva1,2,3, S.S. Savin2,3, V.I. Tishkov1,2,3,* 1Chemistry Department, Lomonosov Moscow State University 2Innovations and High Technologies MSU Ltd 3Bach Institute of Biochemistry, Russian Academy of Sciences *E-mail: [email protected] Received 05.08.2011 Copyright © 2011 Park-media, Ltd. This is an open access article distributed under the Creative Commons Attribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT NAD+-dependent formate dehydrogenase (FDH, EC 1.2.1.2) widely occurs in nature. FDH consists of two identical subunits and contains neither prosthetic groups nor metal ions. This type of FDH was found in different microorganisms (including pathogenic ones), such as bacteria, yeasts, fungi, and plants. As opposed to microbiological FDHs functioning in cytoplasm, plant FDHs localize in mitochondria. Formate dehydrogenase activity was first discovered as early as in 1921 in plant; however, until the past decade FDHs from plants had been considerably less studied than the enzymes from microorganisms. This review summarizes the recent results on studying the physiological role, properties, structure, and protein engineering of plant formate dehy- drogenases. KEYWORDS plant formate dehydrogenase; physiological role; properties; structure; expression; Escherichia coli; protein engineering. ABBREVIATIONS FDH – formate dehydrogenase; PseFDH, CboFDH – formate dehydrogenases from
    [Show full text]
  • Supplementary Materials
    Supplementary materials Figure S1. Serum levels of four uremic metabolites according to CKD groups. The p-values of multiple comparison in each CKD group compared to control are plotted on the graph (ns, not significant; ****, p<0.001). Abbreviations: PS, P-cresyl sulfate; PG, P-cresyl glucuronide; IS, indoxyl sulfate; TMAO, Trimethylamine N-oxide; CKD, chronic kidney disease; ESRD, end stage renal disease. Figure S2. Hypothetical pathway diagram using the KEGG module associated with changes in Oscillibacter contribution according to the renal function. The red and blue arrows represent schematic pathways that increase or decrease the contribution of Oscillibacter as renal function deteriorates, respectively. Small bar charts represent comparison of contribution of Oscillibacter in each orthlogs by groups. Asterisks in bar charts indicate significance (q-value) compared to control group. ns, not significant; *, q<0.05; **, q<0.005. Abbreviation: KEGG, Kyoto Encyclopedia of Genes and Genomes. Table S1. Differentially represented KEGG categories predicted by PICRUSt (level 3) in 4 groups. p-values* Level_1 Level_2 Level_3 p-values* (corrected) Metabolism of Cofactors and Metabolism Riboflavin metabolism 5.93E-05 0.019438 Vitamins Metabolism Carbohydrate Metabolism Pyruvate metabolism 0.000219 0.02393 Metabolism Energy Metabolism Methane metabolism 0.000153 0.025037 Metabolism Others Others_Unclassified 0.000372 0.030475 Biosynthesis of Other Secondary Metabolism Flavonoid biosynthesis 0.00109 0.051083 Metabolites Metabolism of Cofactors
    [Show full text]
  • Inorganic Nitrate Promotes Glucose Uptake and Oxidative Catabolism in White Adipose Tissue Through the XOR Catalyzed Nitric Oxide Pathway
    Page 1 of 35 Diabetes Inorganic Nitrate Promotes Glucose Uptake and Oxidative Catabolism in White Adipose Tissue through the XOR Catalyzed Nitric Oxide Pathway Running Title: Nitrate Enhances Adipose Tissue Glucose Metabolism Ben D McNally1,2†, Amy Moran3†, Nicole T Watt3, Tom Ashmore2,4, Anna Whitehead3, Steven A Murfitt2, Mark T Kearney3, Richard M Cubbon3, Andrew J Murray4, Julian L Griffin1,2,5, Lee D Roberts3* 1. Medical Research Council – Human Nutrition Research, Elsie Widdowson Laboratory, 120 Fulbourn Road, Cambridge, CB2 9NL, UK. 2. Department of Biochemistry and Cambridge Systems Biology Centre, University of Cambridge, 80 Tennis Court Road, Old Addenbrooke's Site, Cambridge, CB2 1GA, UK. 3. Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, LS2 9JT, UK 4. Department of Physiology, Development and Neuroscience, University of Cambridge, Downing Street, Cambridge, CB2 3EG, UK. 5. Biomolecular Medicine, Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, SW7 2AZ, UK. Keywords: Nitrate, White Adipose Tissue, Glucose Metabolism, Metabolomics. † Authors Contributed Equally * Corresponding Authors: Lee D. Roberts. Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, LS2 9JT, UK Email: [email protected] Tel.: +44 1133431050 1 Diabetes Publish Ahead of Print, published online February 21, 2020 Diabetes Page 2 of 35 Tweet: Research from @Roberts_Lab @UoL_LICAMM shows that Inorganic Nitrate, found in high concentration in green leafy vegetables, drives glucose uptake and breakdown in fat cells and fat tissue. #nitrate #adipose #metabolomics. 2 Page 3 of 35 Diabetes Abstract An ageing global population combined with sedentary lifestyles and unhealthy diets has contributed to an increasing incidence of obesity and type 2 diabetes.
    [Show full text]